Invention Grant
- Patent Title: Use of pidotimod to treat irritable bowel syndrome
-
Application No.: US14781755Application Date: 2013-04-05
-
Publication No.: US09408833B2Publication Date: 2016-08-09
- Inventor: Federico Mailland , Francesco Scarci , Maurizio Caserini
- Applicant: POLICHEM SA
- Applicant Address: LU Luxembourg
- Assignee: POLICHEM SA
- Current Assignee: POLICHEM SA
- Current Assignee Address: LU Luxembourg
- Agency: Fredrikson & Byron, P.A.
- International Application: PCT/EP2013/057205 WO 20130405
- International Announcement: WO2014/161594 WO 20141009
- Main IPC: A61K31/427
- IPC: A61K31/427 ; A61K45/06 ; A61K9/00 ; A61K47/10 ; A61K47/12 ; A61K47/18 ; A61K9/06 ; A61K9/08 ; A61K47/36 ; A61K9/16 ; A61K9/20
Abstract:
The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat irritable bowel syndrome. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, may be administered either by oral route or rectally.
Public/Granted literature
- US09446027B2 Use of pidotimod to treat irritable bowel syndrome Public/Granted day:2016-09-20
Information query
IPC分类:
